The cellular redox state is associated with major cellular processes including differentiation, transformation, and apoptosis. Glutaredoxin 2 (Grx2) is a mitochondrial oxidoreductase suggested to play a critical role in protection against apoptotic stimuli. An alternative Grx2 transcript variant encoding a nonmitochondrial protein (Grx2b) was proposed before, but no data was available on the expression of this isoform. We have systematically investigated the expression of Grx2 transcript variants in human tissues and transformed cell lines. The transcript variant encoding mitochondrial Grx2 (Grx2a) was found to be ubiquitously expressed, emphasizing the general importance of the protein for mitochondrial redox homeostasis. In addition, we confirmed the previously suggested isoform Grx2b and identified a new third isoform (Grx2c) derived from alternative splicing of the Grx2b-encoding transcript. In normal tissue expression of both Grx2b and Grx2c was restricted to testes, but additionally we were able to demonstrate transcripts in various cancer cell lines. Both Grx2b and Grx2c are enzymatically active, but only Grx2c can complex the regulatory iron-sulfur cluster described for Grx2a. Expression of GFP fusion proteins suggested a cytosolic and nuclear localization of both Grx2b and Grx2c. Our findings provide the first evidence for functions of Grx2 outside mitochondria.
INTRODUCTION G
LUTAREDOXINS (GRXS) ARE THIOL-DISULFIDE OXIDORE-DUCTASES and part of the thioredoxin (Trx) family of proteins. Grxs are glutathione (GSH)-dependent enzymes involved in the maintenance of cellular redox homeostasis. The proteins react via a monothiol or dithiol mechanism utilizing one or two cysteines in their Cys-Pro-Tyr-Cys active site (5, 11, 30, 45) . First discovered as electron donor for ribonucleotide reductase (RNR) (14, 15) , Grxs are almost ubiquitously present in a growing number of isoforms in most species (51) .
In mammals, two Grxs containing the dicysteine motif in their active site have been identified. Cytosolic Grx1 supports RNR with electrons and is involved in multiple redox-controlled cellular processes (e.g., dehydroascorbate reduction, cellular differentiation, regulation of transcription factors, and apoptosis) (25, 44) . The second mammalian Grx (Grx2) was suggested to be present in at least two alternatively transcribed mRNA isoforms (10, 28) . The human Grx2 gene (GLRX2) is located on chromosome 1 (1q31.2-31.3) and consists of five exons. Exons II to IV form the Grx core, with the unusual active site (Cys-Ser-Tyr-Cys) encoded by exon III. The characteristic GSH-binding motifs are encoded by exons III and IV. Exon Ia encodes a mitochondrial translocation signal; a second putative Grx2 isoform (Grx2b) containing the alternative exon Ib was suggested to be targeted to the nucleus (28) .
Mitochondrial Grx2 (Grx2a) was suggested to play a central role in mitochondrial redox homeostasis by catalyzing the reversible glutathionylation/de-glutathionylation of protein thiols (2) . HeLa cells, in which the expression of Grx was silenced by RNA interference, were dramatically sensitized to cell death induced by oxidative stress-inducing apoptotic agents (26) . The EC 50 for the anticancer drug doxorubicin/adriamycin decreased 60-fold and the EC 50 for phenylarsine oxide, a compound that blocks specifically vicinal dithiols, 40-fold. Corroboratively, overexpression of Grx2 decreased the susceptibility of HeLa cells to apoptosis induced by doxorubicin and the antimetabolite 2-deoxy-D-glucose (8) . Grx2 prevented loss of cardiolipin, inhibited cytochrome c release, and caspase activation. Overexpression of mitochondrial Grx2a provided better protection than overexpression of a cytosolic mutant lacking the mitochondrial translocation signal (8) .
Complex I of the inner mitochondrial membrane is the major source of reactive oxygen species (ROS) for most cells. ROS production results in a decreased ratio of reduced GSH to glutathione disulfide (GSSG) which in turn affects the activity of many key proteins by formation of mixed disulfides of GSH with critical Cys residues (9, 16, 25, 44) . ROS production by complex I correlates with the formation of mixed disulfides of two Cys residues in its NADH binding pocket with GSH (49) . Grx2 efficiently catalyzes the reduction of GSH-mixed disulfides (19) . In fact, Grx2 catalyzes the reversible glutathionylation of complex I under oxidizing conditions. Thus, Grx2 may link the mitochondrial response to redox signals and oxidative stress (2) . Unlike other Grxs, Grx2 can receive electrons not only from GSH but also from the seleno-enzyme thioredoxin reductase (TrxR) (19) . This alternative electron pathway may come into play when the GSH/GSSG ratio or the intracellular pH drops, conditions when Grxs that rely solely on GSH as electron donor are inactive (15) . Human Grx2 was described as the first iron-sulfur protein from the thioredoxin family of proteins. The protein can exist in both the apo-and the dimeric [2Fe-2S] holo-form. Specific co-immunoprecipitation of iron with Grx2 from two different human cell lines suggested the presence of the cluster in vivo. Because only apo-Grx2 is enzymatically active, the cluster was proposed to serve as redox sensor for the activation of the protein during conditions of oxidative stress (27) . Two recent studies demonstrated that the iron-sulfur cluster is complexed by the two N-terminal active site thiols of two Grx2 monomers and two molecules of GSH. The two molecules of GSH are bound noncovalently to the proteins and, in vitro, in equilibrium with GSH in solution (4, 18) . This unusual holo-Grx2 complex may be the basis for the activation of Grx2 upon changes in the cellular redox state. In this model, the holo-Grx2 complex dissociates yielding enzymatically active Grx2, when GSH becomes the limiting factor for cluster coordination. When the active site of human Grx1 (Cys-Pro-Tyr-Cys), which normally cannot bind the cluster, is changed to the corresponding Cys-Ser-Tyr-Cys sequence of Grx2, Grx1 becomes able to complex a [2Fe-2S] cluster as well (4) .
To our knowledge, no study has yet addressed the expression of nonmitochondrial Grx2 isoforms in humans. This lack of direct experimental evidence prompted us to screen various tissues and transformed cells for various Grx2 transcript variants. Our results demonstrate the production of mRNAs corresponding to different Grx2 transcript variants. The transcript variant encoding mitochondrial Grx2a was found ubiquitously, whereas Grx2b transcripts could only be detected in testis and transformed cells. Moreover, we have discovered a third, also testis/cancer-specific, mRNA variant, originated from alternative splicing of the Grx2b encoding pre-mRNA.
MATERIALS AND METHODS

General methods
Chemicals were of analytical grade or better and, unless otherwise stated, purchased from Sigma (St. Louis, MO). Materials for molecular biology were purchased from MBI Fermentas (St. Leon-Rot, Germany). Plasmid DNA was purified from bacteria using the Mini and Midiprep Kit from Qiagen (Hilden, Germany). SDS-PAGE was run using the Novex Mini-Cell and precasted NuPAGE gels (12% acrylamide, BisTris, Invitrogen, Carlsbad, CA), according to the manufacturer's instructions.
Cell culturing
The cell lines investigated, summarized in Table 1 , were cultivated in either DMEM (1 g · l Ϫ1 ) or RPMI 1640 medium supplemented with 10% heat-inactivated fetal calf serum, 2 mM glutamine, and 100 U/ml penicillin and streptomycin mix (PAA, Cölbe, Germany) at 37°C in 90% humidified atmosphere containing 5% CO 2 . To test the expression of Grx2 transcript variants upon hypoxia, HeLa and HEK293 cells were cultivated in DMEM (1 and 4.5 g · l Ϫ1 D-glucose, respectively) at 1% oxygen for 0 (control), 24, 48, or 72 h, whereupon they were trypsinized and harvested.
RNA and cDNA preparation 5 ϫ 10 6 to 10 7 cells from different cell lines were harvested during the log phase of the culture. The cells were washed twice with PBS, scraped off the plate, resuspended in 10 ml PBS, and collected by centrifugation at 1,000 rpm for 5 min. The pellet was resuspended in 100 l PBS ϩ 600 l RNase Later (Ambion, Austin, TX) RNA stabilizing reagent. Total RNA from these cells was prepared using the RNeasy Mini Kit (Qiagen), following the supplied instructions. First strand cDNA was synthesized from 3 g total RNA using the RevertAid H minus First Strand cDNA synthesis Kit (MBI Fermentas) and oligodT primer. For the analysis of Grx2 mRNA isoforms in nonmalignant human tissue, normalized human multiple tissue cDNA panels (I and II) were purchased from Clontech (Mountain View, CA).
Polymerase chain reaction
PCR reactions were performed in programmable thermocyclers from Biometra (Göttingen, Germany) and MJ Research (Biorad, Hercules, CA) in a total volume of 20 l containing 200 M dNTPs, 1.5 mM Mg 2ϩ , ϳ4 ng template cDNA, 0.5 M of each primer, and 1.25 U recombinant Taq Polymerase (MBI Fermentas). The template was denatured at 95°C for 2 min and the following program was repeated 34 times: 95°C for 30 s, 54/60°C for 45 s, 72°C for 40 s. A final elongation step was performed at 72°C for 10 min. The oligonucleotides specific for the glyceraldehyde-3-phosphate dehydrogenase (G3PDH) control were included in the cDNA panels. Grx2 complementary oligonucleotides and further reaction conditions are listed in Table 2 . PCR reactions were analyzed on 1.5-2% agarose gels (120 ml Tris-acetate-EDTA buffer, 14.5 ϫ 19 cm).
Sequencing of PCR fragments
PCR products from agarose gels were extracted using Qiagen's Gel Extraction Kit and directly ligated into the pGEM-T vector (Promega, Madison, WI). Plasmids were sequenced from both 5Ј and 3Ј directions by the sequencing core facility at Karolinska Institutet, KISeq.
Subcellular localization of GFP fusion proteins
The cDNAs encoding Grx2a, Grx2b, and Grx2c were amplified by PCR and cloned into the EcoRI and BamHI sites of both vector pEGFP-N1 and vector pEGFP-C2 (Clontech) that allow the expression of C-and N-terminal GFP fusion proteins in mammalian cells, respectively.
HeLa cells were grown on coverslips in 24-well-plates. Prior to transfection using Exgene 500 (MBI Fermentas), mitochondria were stained with 1 g/ml Mito Tracker Red 580 (Invitrogen, Carlsbad, CA). Cell nuclei were counterstained with Hoechst 33342 (1 g/ml) . The cells were mounted in PBS containing 90% glycerol and analyzed with a Zeiss 510 META confocal laser scanning microscope equipped with an inverted Zeiss Axiovert 200 microscope with a 63 ϫ oil immersion objective (Zeiss, Oberkochen, Germany). Mix dyes were acquired by sequential multiple channel fluorescence scanning to avoid ISOFORMS OF HUMAN GRX2 3 For all oligonucleotides, complementary bases are printed in uppercase, noncomplementary in lowercase.
bleedthrough. Images were processed and colocalization was affirmed using Zeiss Software (LSM 510 Meta).
Protein expression and purification
The Grx2 cDNAs were amplified by PCR adding NdeI and BamH1 sites to the forward and reverse primers, respectively, and cloned into vector pET15b (Novagen, Darmstadt, Germany). PR137 (Grx2c fwd.): CACACACATATGGAGAG-CAATACAATCATCATC, PR131 (Grx2b fwd.): CACACAC-ATATGAACCCTCGAGATAAGCAAG, PR138 (Grx2 rev.): CACACAGGATCCTCACTGAAATTCTTTCCTCTTAC. Grx2 was expressed and purified as described previously (27) . Since expression of Grx2b did not yield soluble protein, we used a modified protocol for in vitro refolding of inclusion body proteins (39) . Cells were disrupted by a combination of lysozyme treatment and sonication. The crude extract was centrifuged at 20,000 g for 30 min. The pellet containing inclusion bodies was resuspended in 50 mM sodium phosphate buffer, pH 8, 300 mM NaCl, and 1 % Triton-X100 and centrifuged at 12,000 g for 30 min. The pellet was resuspended in 50 mM sodium phosphate buffer, pH 8, containing 300 mM NaCl, and centrifuged again. Next, the pellet was resuspended in 6 M guanidine HCl, 100 mM dithiotreitol, and 100 mM Tris/HCl, pH 8, and incubated during gentle shaking for 2 h at room temperature. The solution was centrifuged at 20,000 g for 30 min. Dithiotreitol was removed from the supernatant using prepacked Sephadex G-25 gelfitration columns (Amersham, Upsalla, Sweden) equilibrated with 6 M guanidine HCl, and 100 mM Tris/HCl, pH 8. The protein was purified by immobilized metal affinity chromatography using Talon (Novagen). Unspecific bound protein was removed by two wash steps with 50 mM sodium phosphate, pH 8, 300 mM NaCl, 6 M guanidine HCl, and the same buffer containing 50 mM imidazole. The protein was eluted in the washing buffer containing 300 mM imidazole. The pure protein was gently refolded by dialysis (MWCO: 6-8 kDa, Spectrum) against 200 ml washing buffer and, over a period of 20 h, slowly increasing amounts of 2 l of 50 mM sodium phosphate buffer, pH 8, 300 mM NaCl at 4°C. Residual guanidine and imidazole were removed using Sephadex G25 columns equilibrated with the dilution buffer.
[Fe,S] cluster reconstitution
Iron-sulfur cluster reconstitution was performed as described in detail in reference (4).
Spectroscopy
UV-VIS spectra were recorded with a Shimadzu (Kyoto, Japan) UV-2100 two beam spectrophotometer. Circular dichroism (CD) spectra were recorded using an Aviv (Lakewood, NJ) 202SF spectropolarimeter with a 1 mm path-length sealed cuvette at 25°C and a scan rate of 1 nm min Ϫ1 . Reference spectra were subtracted from the average of four spectra recorded over a range of 190-260 nm using 7.4-15 M protein in a buffer containing 5 mM potassium phosphate, pH 8, and 100 mM KCl.
Immunological detection of Grx2
Antisera against human Grx2 were raised against the common part of Grx2a and Grx2b (28) . This common part is identical to Grx2c. The Grx2-specific ELISA was performed as described before (29) . The standard curves were calculated by regression analysis applying a four-parameter logistic equation using Grace (http://plasmagate.weizmann.ac.il/Grace, last accessed November 20, 2007) .
Proteins from polyacrylamide gels were transferred onto nitrocellulose membrane (BioRad) by wet transfer as suggested by the manufacturer (Invitrogen NuPage Mini-Cell). After blocking the membranes for 1 h at room temperature in phosphate-buffered saline (PBS, 137 mM NaCl, 3 mM KCl, 6.5 mM NaHPO, 1.5 mM KH 2 PO 4 ) containing 0.5% Tween-20 and 5% nonfat dry milk powder (Semper, Stockholm, Sweden), rabbit anti-Grx2 antibodies, or (NH 4 ) 2 SO 4 -precipitated serum from an Grx2 immunized rabbit, were added to a final dilution of 1:2,000 and 1:1,000, respectively, and left to incubate at 4°C overnight. To prove the specificity of the serum, a negative control was used where the serum was pre-incubated for 1 h with 100 g of pure Grx2. The antigen-antibody complexes were identified by incubation with biotin-coupled anti-rabbit antibodies (1:1,000, Dako, Glostrup, Denmark) for 1 h at room temperature in blocking buffer, followed by incubation of alkaline phosphatase-conjugated streptavidin (1:1,000) in PBS plus 0.5% Tween-20, 5% BSA, and 0.02% NaN 3 . The antibody binding was visualized using NBT/BCIP (Roche, Mannheim, Germany).
For the identification of Grx2 isoforms by immunocytochemistry, cDNAs encoding the three different Grx2 isoforms were amplified by PCR and cloned into the NheI and BglII sites of vector pExpress (1). Prior to transfection of HeLa cells using Nanofectine as suggested by the manufacturer (PAA), cells were counter stained with 200 nM Mitotracker Deep Red 633. Twenty-four hours after transfection, cells were fixated with 4% paraformaldehyde (Merck, Darmstadt, Germany) for 30 min. Next, the cells were washed with PBS (3 times, 5 min) followed by permeabilization and blocking with blocking buffer (10 mM HEPES, 0.3% Triton X-100, 3% BSA) for 1 h. Subsequently, the samples were incubated with anti-Grx2 antibodies diluted 1:1,000 in blocking buffer over night at 4°C. Following three washing steps with PBS for 5 min, immunocomplexes were detected with Alexa 488-coupled anti-rabbit antibodies (Invitrogen). When indicated, nuclei were counterstained with 1 ng/l Hoechst 33342 (Sigma). Images were recorded with a Leica TCS SP2 confocal laser scanning microscope using a 40ϫ oil planapochromat lens (Leica, Heidelberg, Germany). Deconvolution and analysis of co-localization was performed using the software package Huygens (Scientific Volume Imaging, Hilversum, The Netherlands).
Paraffin-embedded slides of human testis were purchased from ProSci Incorporated (Poway, CA). The sections were deparaffinized in xylene and rehydrated in ethanol to distilled water. Tissue was processed with the peroxidase-anti-peroxidase method as described in Ref. 6 , with minor modifications. Briefly, endogenous peroxidase was blocked by incubating the sections for 30 min in PBS containing 1% H 2 O 2 . Following three times washing in PBS, the tissue was penetrated for 2.5 h using PBS containing 0.1% Triton X-100 (PBST). Next, the sections were incubated for 40 h at 4°C in the presence of the Grx2 antibody (1:50). The samples were washed three times in PBST, and incubated with a biotinylated anti-rabbit antibody (1:200 Vector) in PBST for 1 h. Finally, the sections were incubated with 100 l of an ABC-complex, washed two times with both PBS and 0.2 M acetate buffer, and developed with 0.035% 3.3˛-diaminobenzidine. Following 10 min wash in PBST and dehydration, sections were mounted and examined with a Zeiss Axiophot microscope. Adobe Photoshop 8.0-www.adobe.com (074122)-was used for processing and analyzing the images.
Enzymatic assays
Enzymatic activity of Grx with GSH as electron donor was determined using the HED assay (31)
RESULTS
For the analysis of Grx2 mRNA variants, we have screened human tissues for the following fragments: (a) exons II, III, and IV, representing the common/core part of the human Grx2 variants, (b) exons Ia, II, III, and IV, encoding the mitochondrial isoform Grx2a, and (c) exons Ib, II, III, and IV, encoding the previously suggested Grx2b (28).
Grx2 mRNA isoforms in nonmalignant human tissue
Grx2 mRNA variants in nonmalignant human tissues were analyzed using commercially available normalized first strand cDNA from heart, brain, placenta, lung, liver, skeletal muscle, kidney, pancreas, spleen, thymus, prostate, testis, ovary, small intestine, colon, and leukocyte. Figure 1 shows representative pictures from the PCRs separated by gel electrophoresis. Pooled cDNA served as tissue-independent positive control. First, we screened the different tissues for the common part of the expected Grx2 transcript variants, represented by exons II to IV. The presence of one band in each sample with only minor differences in intensity demonstrated that Grx2 mRNA was present in all tissues analyzed (Fig. 1, second panel) , confirming previous findings (28) . Similar results were obtained for the mitochondrial isoform (exons Ia, to IV); one band of the expected size (see Table 2 ) with small differences in intensity in all samples was observed (Fig. 1, third panel) . In contrast, PCRs specific for the previously suggested second isoform (exons Ib. II, III, and IV) yielded products only in cDNA derived from testes (Fig. 1, bottom panel) . Unexpectedly, the PCRs yielded two products. One band of the expected size of ϳ480 bp, and a second of ϳ380 bp. A representative EST clone that was used as positive control yielded only the expected reaction product of 480 bp.
Grx2 in transformed cells
Many cancer cells show alterations in expression levels of enzymes involved in oxidative stress response. We therefore screened a number of human cancer cell lines (see Table 1 ) derived from blood, breast, cervix, lung, and the nervous system. As before, we obtained nearly equally strong bands in our control reaction (exons II to IV) and in reactions specific for the mitochondrial isoform (exons Ia to IV, Fig. 2 ), supporting the idea that Grx2 may be highly expressed in cancer cells (28) . In contrast to normal tissue, the testis-specific Grx2b isoform was detected in about two-thirds of all analyzed samples. Again, the reactions yielded two bands of ϳ380 and 480 bp. However, the ratio between these bands differed significantly among the cell lines. IARC139, BL30, DFSK-1, D283, HCC1937, A549, and HeLa cells yielded approx. equally strong signals for both fragments. BL28 cells contained mainly the smaller fragment, SK-N-F1, and SK-N-AS, D324, H23, and Jurkat cells gave rise mainly to the larger fragment. Testis and solid cancer tissue exhibit the lowest oxygen concentrations in the human body. To investigate the influence of these hypoxic conditions on the expression of Grx2 mRNA variants, we propagated HeLa and HEK293 cells at 1% oxygen for up to 72 h, however, we could not detect significant differences in expression pattern (data not shown).
A new third human Grx2 isoform
To investigate the nature of the two products obtained from the exon 1b-specific PCRs, we extracted and sequenced them
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FIG. 1. RT-PCR screen for human Grx2 mRNA isoforms in various tissues
. cDNAs from multiple tissue cDNA panels were used as templates. G3PDH and Grx2 exon II to IV fragments were amplified as controls. Pooled cDNA was used as tissue-independent control. The negative control contained water instead of template. A plasmid containing a full-length Grx2b EST clone was used as additional positive control for the exon Ib to exon IV-specific PCR.
from both testis and several cell lines. All samples yielded the same results, depicted in Fig. 3 , demonstrating that the two products were derived from alternative splicing events. Exon Ib contains two alternative splice donor sites (Fig. 3B) . The previously suggested Grx2b isoform (i.e., the 480 bp fragment) was derived from full-length exon Ib. An alternative splice donor site, located 101 bp upstream, gave raise to the 380 bp fragment.
The longest possible open reading frame for this transcript variant ranges from the ATG at the beginning of exon II to the termination site in exon IV (Fig. 3 ), thus yielding a new isoform named Grx2c.
Subcellular localization of the isoforms
To confirm the subcellular localization of Grx2a in mitochondria (9, 28) and investigate the localization of Grx2b and Grx2c, we followed two independent strategies. First, we have expressed both N-and C-terminal GFP fusion proteins in HeLa cells (Fig. 4A) . Our results confirm the mitochondrial localization of Grx2a mediated by an N-terminal transit peptide as seen from the mitochondrial staining of Grx2a-GFP transfected cells and the diffuse, unspecific staining of GFP-Grx2a transfected cells (Fig. 4A, 1st column) . Unlike previously suggested (28), we could not confirm an exclusive nuclear or perinuclear staining of cells expressing Grx2b-GFP or GFP-Grx2b (Fig. 4A, 2nd  column) . Instead, expression of these proteins as well as expression of the corresponding Grx2c-GFP fusion proteins (Fig.  4A, 3rd column) led to a diffuse staining of the cells, indicating both cytosolic and nuclear localization of these proteins. Second, to rule out possible artifacts resulting from the GFP fusion protein, we transiently expressed the three Grx2 isoforms without GFP fusion at medium levels (approximately threefold overexpression when quantified by ELISA) and investigated the localization of the proteins in fixated cells by immunocytochemistry. The results, depicted in Fig. 4B , corroborate the results outlined above. Grx2a was identified in mitochondria, Grx2b and Grx2c were detected in both the cytosol and nucleus. This distribution did not change when the cells were stressed with hydrogen peroxide, cumene peroxide, or doxorubicin for different time points prior to fixation (not shown).
Characterization of Grx2b and Grx2c
With respect to primary structure, the newly discovered cytosolic isoform Grx2c is almost identical to processed mitochondrial Grx2a (28) , that has been analyzed thoroughly biochemically and biophysically before. Grx2b contains an N-terminal extension. The fact that the subcellular distribution of Grx2b was not affected when the proteins were expressed as N-or C-terminal GFP fusion protein suggests that this exten- 
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FIG. 2. RT-PCR screen for human
Grx2 mRNA isoforms in cancer cell lines. cDNAs reversely transcribed from total RNA using oligo-dT primer were used as PCR templates. G3PDH and Grx2 exon II to IV fragments were amplified as controls. Pooled cDNA was used as independent control. The negative control contained water instead of template. A plasmid containing the full Grx2b EST clone and testis cDNA were used as positive controls for the exon Ib to exon IV-specific PCR. The origins of the different cell lines are listed in Table 1 . sion does not function as signal peptide. This is in agreement with predictions from bioinformatics (not shown). Despite of multiple strategies, we were not able to express Grx2b in soluble form in E. coli. However, we were able to refold the protein in vitro. CD spectra recorded for refolded Grx2b and native Grx2c were almost identical (not shown). Moreover, when assayed for enzymatic activity using GSH as electron donor and the mixed disulfide between GSH and â-mercaptoethanol formed in the HED assay as substrate, refolded Grx2b exhibited essentially the same specific activity as Grx2c (i.e., 16.2 Ϯ 4.8 and 16.9 Ϯ 4.1 U mg Ϫ1 , respectively). With TrxR as electron donor, Grx2b reduced GSSG with a specific activity of 15.3 Ϯ 3.3 compared to 29.7 Ϯ 3.5 mU mg Ϫ1 determined for Grx2c. This value for Grx2c did not change significantly when the protein was objected to the denaturation/refolding procedure applied to Grx2b.
We next analyzed the ability of Grx2b to form the ironsulfur cluster-bridged dimer using the recently established in vitro reconstitution assay (4). As depicted in Fig. 5, Grx2c , but not the refolded Grx2b, was able to form the holo-complex. Iron-sulfur cluster biosynthesis is dependent on mitochondria, but can take place in the cytosol as well (24) . Thus, both cytosolic and nuclear Grx2 may harbor an iron-sulfur cluster in vivo.
Identification of Grx2 protein isoforms
To investigate how well the antigen-purified antibodies raised against Grx2 (29) may recognize both folded and denatured Grx2b, we analyzed the protein by ELISA and Western blotting. In ELISA, Grx2b reacts with about fivefold lower sensitivity compared to Grx2c (Fig. 6A) . In Western blotting, no significant difference in sensitivity was seen between the isoforms (Ϯ11%, Fig. 6B ). However, the sensitivity in general was too low to identify Grx2 in cellular extracts. To overcome this problem, serum was used instead of affinity purified antibodies. This way, we were able to obtain three weak but specific signals in HeLa extracts of approx. 14.5, 15, and 18 kDa (Fig.  6C) . These bands correspond well to the calculated molecular weights of Grx2c (14.1 kDa), processed Grx2a (15 kDa), and Grx2b (18.8 kDa).
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Grx2a
Grx2x-GFP
GFP-Grx2x
Grx2b Grx2c To shed some light on possible functions of Grx2 in human testicles, we studied the distribution of Grx2 in the different cell types of the testicle (Fig. 7) . Grx2 immunolabeling resulted in a more consistent and strong staining in spermatids [i.e., in both round (RS) and elongated spermatids (ES)]. Specific Grx2 staining was also observed in spermatogonia (SP) and Sertoli cells (SER). In general, the labeling increased during spermatid development and appeared to be concentrated in the cytoplasm.
DISCUSSION
Alternative splicing and transcription initiation mechanisms greatly increase the number of functionally different proteins transcribed from a particular gene. Multiple transcript variants were proposed for both human and mouse Grx2, however, so far only one transcript variant encoding the mitochondrial isoform of mammalian Grx2 (Grx2a) has been demonstrated experimentally (10, 21, 28) . Here, we have identified and confirmed two additional transcript variants of human Grx2 whose expression is restricted to testicular tissue and transformed cells.
Mitochondrial Grx2a, and its supposedly cytosolic/nuclear siblings Grx2b and Grx2c, share the same Grx core domain encoded by exons II, III, and IV of the GLRX2 gene (Fig. 3d) . Grx2a, once it has been processed during mitochondrial translocation, and Grx2c are essentially the same protein. They can both receive electrons from GSH as well as TrxR in vitro and they can both complex the regulatory iron-sulfur cluster. Grx2b, on the other hand, may be constitutively active or regulated by other mechanisms, since the protein cannot form the dimeric holo-complex. This finding may be caused by a lack of structural integrity of the refolded Grx2b protein, however, it may as well indicate a different accessibility of the active site for protein-protein interactions, that could interfere with dimerization. This assumption is supported by the decreased activity of Grx2b with TrxR. The physiological functions of reduction by TrxR and the iron-sulfur cluster complexes remain to be established.
Grx2b has previously been suggested to be a nuclear protein, based on the observation that HeLa cells expressing a Grx2b-GFP fusion protein showed a dotted fluorescence pattern located predominantly in the perinuclear area. A positive stretch of amino acids in the C-terminus of the protein was suggested to constitute a nuclear localization signal (28) . In our hands, the cells expressing neither Grx2b-GFP nor the GFP-Grx2b exhibited this pattern. Instead, we have seen a diffuse cytosolic and nuclear localization. To rule out artifacts induced by the GFP fusion partner and the fixation procedure, we have also analyzed HeLa cells recombinantly expressing the three (tag-free) Grx2 isoforms at medium levels by immunocytochemistry. These experiments yielded essentially the same distribution of the three isoforms as described above. What else could be the reason for this significant difference to the previous study? Notably, the article by Lundberg et al. (28) T-cells. This may point to different subcellular distributions in different cell types. A second possible explanation could be a dynamic distribution of Grx2b and maybe even Grx2c between cytosol and nucleus. However, we could not detect any changes in subcellular distribution when the cells were objected to oxidative stress prior to analysis. Further studies will address this question. Alternative transcript variants have also been reported for other members of the mammalian Trx family of proteins. Three splice variants of cytosolic Trx1 lacking exon III, exons II and III, and the poly A-tail, respectively, have been described (3, 13, 17) . Two Grx1 variants have been described that differ in the 3Ј untranslated regions but share the same open reading frame (34) . An intriguingly complex transcription and splicing pattern has been revealed for cytosolic TrxR1 (33, 40, 46) . Remarkably, one of these transcript variants contains a glutaredoxin domain fused to the N-terminus of TrxR1 and is, as various other N-terminal TrxR1 variants, primarily expressed in testes (46) . In a strikingly similar manner, the homologous thioredoxin-glutathione reductase (TGR) is composed of an Nterminal Grx domain and a C-terminal TrxR domain and is predominantly expressed in testes, particularly in elongated spermatids (47) . Another seleno-oxidoreductase worth mentioning is phospholipid hydroperoxide reductase (PHGPx). This GSH peroxidase is, by means of alternative splicing, expressed in three isoforms: the ubiquitously present cytosolic form and two testis-specific isoforms targeted to mitochondria and the nucleus, respectively (22, 35, 36, 42) . PHGPx exists as soluble enzyme in spermatids but persists in mature sperm as structural, insoluble, oxidatively cross-linked protein representing the major component of the mitochondrial midpiece capsule (50) . It was proposed that TGR and PHGPx together serve as a disulfide bond formation system during spermatogenesis (47) . Furthermore, testicular cells are equipped with a series of tissuesspecific members of the Trx family of proteins (32) .
What could be the functions of Grx2b and Grx2c in testis and transformed cells? The restriction to testis may well reflect the special redox requirements of this organ. Spermatogenesis is a highly complex process of cellular differentiation, and oxidative crosslinking of proteins by means of specific disulfide linkages plays an important role in sperm maturation (43, 48) . In this respect, nonmitochondrial Grx2 may act as disulfide isomerase in different compartments, a possible function that has been previously described for Grxs (41, 52) . This assumption is also consistent with the increase in Grx2 immunostaining during spermatid development.
Many genes predominantly expressed in testis and malignancies have suggested functions in cell cycle regulation, transcriptional control, or cell survival (53) . In HeLa cells, Grx2 plays a major role in cell survival upon treatment of the cells with oxidative stress-inducing apoptotic agents (26) . Overexpression of both mitochondrial Grx2a and of a cytosolic mutant (identical to Grx2c identified here) provided protection from apoptosis induced by the anti-cancer agents doxorubicin/adriamycin and 2-deoxy-D-glucose. The protection by cytosolic Grx2 was less efficient, especially after treatment with 2-deoxy-D-glucose (8) . The ubiquitous expression of Grx2a may thus reflect the general importance of this isoform in maintenance of mitochondrial redox homeostasis. The apparent restricted expression of the supposedly cytosolic/nuclear Grx2 isoforms may be consistent with functions in cellular differentiation and transformation.
RNR can use electrons from both Trxs and Grxs for the supply of DNA synthesis with deoxynucleotides (14, 23) . In mammalian cells, however, the importance of these proteins as electron donor is not well understood, because the tissue distribution of these redoxins is not related to cell proliferation or DNA synthesis (37) . One might therefore speculate about a function of cytosolic Grx2 as electron donor for RNR in the highly proliferative spermatogonia cells that contain both RNR and Grx2 but neither Trx1 nor Grx1 (12, 38) . More research is required to analyze this possibility.
DNA methylation is the main mechanism controlling the expression of testis/cancer-associated genes (53) . This epigenetic regulation is based on the methylation of cytosines in so-called CpG islands (20) . These regions are often located in the 5Ј regulatory sequences of genes (7) . Could this be the mechanism regulating the expression of Grx2 isoforms? In support of this hypothesis, the human GLRX2 gene contains two potential CpG islands in its 5Ј region. The first one is located directly upstream of exon Ib and covers the potential promotor of Grx2b and Grx2c (length ϭ 232 bp, %GC ϭ 60.7, obs/exp CpG ϭ 0.7). The second one covers exon Ia and the predicted promotor of the Grx2a isoform (length ϭ 720 bp, %GC ϭ 67.3, obs/exp CpG ϭ 0.88).
In conclusion, we have demonstrated the ubiquitous expression of Grx2's mitochondrial isoform (Grx2a) in human tissues. We have confirmed and identified two alternative transcript variants expressed exclusively in testis and transformed cells that encode cytosolic/nuclear proteins. Our results provide evidence for the expression of the proteins corresponding to these transcripts in vivo. Together, the results presented here provide the first evidence for potential roles of Grx2 in cellular differentiation and tumor progression.
